Literature DB >> 20647231

Cancer incidence and incidence rates in Japan in 2004: based on data from 14 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project.

Tomohiro Matsuda1, Tomomi Marugame, Ken-ichi Kamo, Kota Katanoda, Wakiko Ajiki, Tomotaka Sobue.   

Abstract

The Japan Cancer Surveillance Research Group estimated the cancer incidence in 2004 as part of the Monitoring of Cancer Incidence in Japan (MCIJ) project, on the basis of data collected from 14 of 31 population-based cancer registries. The total number of incidences in Japan for 2004 was estimated as 623,275 (C00-C96). The leading cancer site according to the crude and age-standardized incidence rates was the stomach for men and breast for women. The apparent increase in age-standardized incidence rates in 2003 was calmed down in 2004.

Entities:  

Mesh:

Year:  2010        PMID: 20647231     DOI: 10.1093/jjco/hyq109

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  14 in total

1.  Significance of prostate-specific antigen kinetics after three-dimensional conformal radiotherapy with androgen deprivation therapy in patients with localized prostate cancer.

Authors:  Wataru Fukuokaya; Sangji Kim; Takao Natsuyama; Kanako Matsuzaki; Homare Shiomi; Hiroki Kitoh; Nobuko Utsumi; Hiromasa Kurosaki; Masafumi Inoue; Koichiro Akakura
Journal:  Int J Clin Oncol       Date:  2017-11-18       Impact factor: 3.402

Review 2.  Prostate cancer in Asian men.

Authors:  Kazuto Ito
Journal:  Nat Rev Urol       Date:  2014-03-04       Impact factor: 14.432

3.  The prevalence and associated factors of colorectal neoplasms in acromegaly: a single center based study.

Authors:  Masaaki Yamamoto; Hidenori Fukuoka; Genzo Iguchi; Ryusaku Matsumoto; Michiko Takahashi; Hitoshi Nishizawa; Kentaro Suda; Hironori Bando; Yutaka Takahashi
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

4.  Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design.

Authors:  Noriaki Ohuchi; Takanori Ishida; Masaaki Kawai; Yoko Narikawa; Seiichiro Yamamoto; Tomotaka Sobue
Journal:  Jpn J Clin Oncol       Date:  2010-12-02       Impact factor: 3.019

5.  Comparison of Age- Standard Incidence Rate Trends of Gynecologic and Breast Cancer in Iran and Other Countries.

Authors:  Maliheh Arab; Giti Noghabaei
Journal:  Iran J Public Health       Date:  2014-10       Impact factor: 1.429

6.  Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan.

Authors:  Mai Utada; Yuko Ohno; Tomoko Tamaki; Tomotaka Sobue; Ginji Endo
Journal:  J Epidemiol       Date:  2014-03-07       Impact factor: 3.211

7.  Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer.

Authors:  Taiki Masuda; Toshiaki Ishikawa; Kaoru Mogushi; Satoshi Okazaki; Megumi Ishiguro; Satoru Iida; Hiroshi Mizushima; Hiroshi Tanaka; Hiroyuki Uetake; Kenichi Sugihara
Journal:  Int J Oncol       Date:  2016-01-11       Impact factor: 5.650

8.  Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer.

Authors:  Kosaku Harada; Hitoshi Ishikawa; Yoshitaka Saito; Soken Nakamoto; Hidemasa Kawamura; Masaru Wakatsuki; Toru Etsunaga; Yutaka Takezawa; Mikio Kobayashi; Takashi Nakano
Journal:  J Radiat Res       Date:  2012-08-01       Impact factor: 2.724

9.  A novel serum metabolomics-based diagnostic approach for colorectal cancer.

Authors:  Shin Nishiumi; Takashi Kobayashi; Atsuki Ikeda; Tomoo Yoshie; Megumi Kibi; Yoshihiro Izumi; Tatsuya Okuno; Nobuhide Hayashi; Seiji Kawano; Tadaomi Takenawa; Takeshi Azuma; Masaru Yoshida
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

10.  Dihydrotestosterone synthesis pathways from inactive androgen 5α-androstane-3β,17β-diol in prostate cancer cells: Inhibition of intratumoural 3β-hydroxysteroid dehydrogenase activities by abiraterone.

Authors:  Takashi Ando; Tsutomu Nishiyama; Itsuhiro Takizawa; Fumio Ishizaki; Yoshimichi Miyashiro; Keisuke Takeda; Noboru Hara; Yoshihiko Tomita
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.